These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12749728)

  • 1. Proteomic prediction of disease outcome in cancer : clinical framework and current status.
    Steinert R; von Hoegen P; Fels LM; Günther K; Lippert H; Reymond MA
    Am J Pharmacogenomics; 2003; 3(2):107-15. PubMed ID: 12749728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
    Ali M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics for Early Diagnostics.
    Mali SB
    J Craniofac Surg; 2015 Jun; 26(4):1013-4. PubMed ID: 26080113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.
    Ganesh SK; Skelding KA; Mehta L; O'Neill K; Joo J; Zheng G; Goldstein J; Simari R; Billings E; Geller NL; Holmes D; O'Neill WW; Nabel EG
    Pharmacogenomics; 2004 Oct; 5(7):952-1004. PubMed ID: 15469413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of proteomics in the diagnosis and outcome prediction in colorectal cancer.
    Steinert R; Buschmann T; van der Linden M; Fels LM; Lippert H; Reymond MA
    Technol Cancer Res Treat; 2002 Aug; 1(4):297-304. PubMed ID: 12625789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-Based Proteomics.
    Wingren C
    Adv Exp Med Biol; 2016; 926():163-179. PubMed ID: 27686812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics of cancer of hormone-dependent tissues.
    Tyson DR; Ornstein DK
    Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting cancer drug response by proteomic profiling.
    Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
    Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics in cancer: Where we are.
    Panis C; Pizzatti L; Souza GF; Abdelhay E
    Cancer Lett; 2016 Nov; 382(2):231-239. PubMed ID: 27561426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical potential of proteomics in the diagnosis of ovarian cancer.
    Ardekani AM; Liotta LA; Petricoin EF
    Expert Rev Mol Diagn; 2002 Jul; 2(4):312-20. PubMed ID: 12138495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics and protein analyses of ovine and caprine body fluids: current studies and future promises.
    Mavromati J; Cash P; Restelli L; Soler L
    Curr Protein Pept Sci; 2014 Feb; 15(1):45-55. PubMed ID: 24555895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of proteomic technologies to tumor analysis.
    Misek DE; Imafuku Y; Hanash SM
    Pharmacogenomics; 2004 Dec; 5(8):1129-37. PubMed ID: 15584879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics technologies for the global identification and quantification of proteins.
    Brewis IA; Brennan P
    Adv Protein Chem Struct Biol; 2010; 80():1-44. PubMed ID: 21109216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer proteomics: Serum diagnostics for tumor marker discovery.
    Rai AJ; Chan DW
    Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.